This inventor holds 5 USPTO granted patents. Top assignees: Amgen Inc., The Rockefeller University. Active years: 1994-1998.
Company Filing History:
5 out of 2,069 
2 out of 751 
Years Active: 1994-1998
Title: Henri Stephen Lichenstein: Innovator in Biochemistry
Introduction
Henri Stephen Lichenstein is a notable inventor based in Ventura, CA (US). He has made significant contributions to the field of biochemistry, particularly through his innovative patents. With a total of 5 patents, Lichenstein has focused on developing solutions that address critical health issues.
Latest Patents
Among his latest inventions are two noteworthy patents. The first is related to anti-inflammatory CD14 peptides, which are designed to mitigate inflammation through specific peptide regions of CD14. The second patent introduces Afamin, a novel human serum albumin-like protein. This invention highlights a protein with activities similar to human serum albumin, human alpha-fetoprotein, or human vitamin D binding protein, and it has an apparent molecular weight of 87 kd.
Career Highlights
Lichenstein has had a distinguished career, working with prominent organizations such as Amgen Inc. and The Rockefeller University. His work in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.
Collaborations
Throughout his career, Lichenstein has collaborated with esteemed colleagues, including Samuel D. Wright and David Edwin Lyons. These partnerships have fostered a collaborative environment that has led to innovative breakthroughs in his field.
Conclusion
Henri Stephen Lichenstein's contributions to biochemistry through his patents and collaborations underscore his role as a leading inventor. His work continues to impact the scientific community and improve health outcomes.